The use of biochemical markers of bone turnover in osteoporosis. Committee of Scientific Advisors of the International Osteoporosis Foundation.
about
Low-frequency vibratory exercise reduces the risk of bone fracture more than walking: a randomized controlled trialEuropean guidance for the diagnosis and management of osteoporosis in postmenopausal womenHormone replacement therapy, calcium and vitamin D3 versus calcium and vitamin D3 alone decreases markers of cartilage and bone metabolism in rheumatoid arthritis: a randomized controlled trial [ISRCTN46523456]Effects of resistance training and protein supplementation on bone turnover in young adult womenTeriparatide for osteoporosis: importance of the full coursePINP as a biological response marker during teriparatide treatment for osteoporosisMetabolomics and Its Application in the Development of Discovering Biomarkers for Osteoporosis ResearchChanges of bone formation markers osteocalcin and bone-specific alkaline phosphatase in postmenopausal women with osteoporosisBone mineral density, osteocalcin, and bone-specific alkaline phosphatase in patients with insulin-dependent diabetes mellitusDocosahexaenoic acid and 17 beta-estradiol co-treatment is more effective than 17 beta-estradiol alone in maintaining bone post-ovariectomy.Study protocol--metabolic syndrome, vitamin D and bone status in South Asian women living in Auckland, New Zealand: a randomised, placebo-controlled, double-blind vitamin D interventionPrediction of changes in bone mineral density in postmenopausal women treated with once-weekly bisphosphonates.Reduced bone turnover in mice lacking the P2Y13 receptor of ADP.Bone biomarker for the clinical assessment of osteoporosis: recent developments and future perspectives.Effects of total flavonoids from Drynariae Rhizoma prevent bone loss in vivo and in vitro.A cross-sectional evaluation of the effect of risperidone and selective serotonin reuptake inhibitors on bone mineral density in boys.Are we taking full advantage of the growing number of pharmacological treatment options for osteoporosis?Bone mass and turnover in women with epilepsy on antiepileptic drug monotherapy.Osteopenia due to enhanced cathepsin K release by BK channel ablation in osteoclasts.Bone mineral density in residents of care facilities for the aged and effect of pharmacotherapy.Prevention of disuse osteoporosis in rats by Cordyceps sinensis extract.Bone and glucose metabolism: a two-way streetCathepsin K in treatment monitoring following intravenous zoledronic acidThe effects of organic nitrates on osteoporosis: a randomized controlled trial [ISRCTN94484747]Skeletal aspects of Gaucher disease: a review.Efficacy of strontium ranelate in combination with a D-hormone analog for the treatment of postmenopausal osteoporosis.Recent advances in the use of serological bone formation markers to monitor callus development and fracture healingBiochemical markers for assessment of calcium economy and bone metabolism: application in clinical trials from pharmaceutical agents to nutritional products.Harmonised Australian Reference Intervals for Serum PINP and CTX in AdultsEthnic differences in urinary calcium and phosphate excretion between Gambian and British older adults.Bone health in young women with epilepsy after one year of antiepileptic drug monotherapy.Matrix metalloproteinases (MMP) and cathepsin K contribute differently to osteoclastic activities.Clinical utility of bone markers in the evaluation and follow-up of osteoporotic patients: why are the markers poorly accepted by clinicians?Biochemical markers of bone metabolism in animals: uses and limitations.Exercise training in obese older adults prevents increase in bone turnover and attenuates decrease in hip bone mineral density induced by weight loss despite decline in bone-active hormones.Hip fracture prevention. Drug therapies and lifestyle modifications that can reduce risk.Cartilage turnover assessed with a newly developed assay measuring collagen type II degradation products: influence of age, sex, menopause, hormone replacement therapy, and body mass indexEffects of OsteoKing on osteoporotic rabbitsVitamin E reversed nicotine-induced toxic effects on bone biochemical markers in male rats.Effect of weight loss on bone health in overweight/obese postmenopausal breast cancer survivors
P2860
Q21257153-2061097D-7A55-44D6-BC7D-668529D8D329Q24612411-7D4F2FD6-2ECE-4A50-A95A-1B4535D493DDQ24796830-E20DCA32-7DFA-4A9F-9C3B-10A5EAE852F6Q24814112-B8799B79-A81E-435E-AE05-A0FBA67E58D9Q26768410-AD0F44EF-7223-4878-88A6-8710E4EF9464Q26859267-7273F216-69AB-48BA-8382-AED1050F643BQ28068862-C56ECBC3-ED6C-400C-AD48-86B29F6DD0B9Q28258459-953A1DF4-53C0-41C6-AD75-B2323DBA08BDQ28258467-95C74788-4904-46E5-B95A-57ED33ED02B3Q33326239-4EFB489D-E016-425E-B35C-6E2AE878E51DQ33356265-BF2485E1-FCDE-487B-A584-58571BF35F62Q33569806-C1D6A84A-2B01-49D4-92BD-820AFE2A20F5Q33636713-71CE6775-8D19-4E56-85F4-B4F9C8FAFCECQ33702810-3BDA416F-FB16-403E-93EF-A8A561BFE50EQ33716948-16B5D567-5922-4D9B-8BC7-ADA59E19767BQ33755068-D6E04A64-C8B5-4A5F-B7BF-BBDB0CCCA499Q33811677-EE34697C-0016-4C6E-89AF-3035D0DD87C7Q33915150-3B657DC9-EEDE-4B0F-9F43-370F8BE37845Q33939383-513E6F22-E064-4FEC-9E7B-83861DB3FA6AQ33948822-AC8AEF6B-A9D7-4FEA-888A-533862EF2B20Q34096882-6FD9E6A7-4F8F-460B-B8FD-60FE76427F1AQ34160465-9AD8EAB5-872E-42ED-A80B-C9E3DF2285A9Q34265281-05529014-DA75-474A-A99F-EB38EBF404EEQ34646490-1DF02995-87F5-4395-92AF-78A0207CC6D1Q34661021-2577A4E5-C5A7-4E9D-B88D-65F86C613985Q34727815-630ACA3B-D638-4000-BE49-DEBD6C2D237FQ34759492-76AB9BA5-2A28-4518-8625-1D18AF080626Q35017714-4CB8C89F-A24E-46DB-90BF-CC616B176BE1Q35025198-56958C77-2711-48D3-8DB9-0B66A0572C69Q35092647-CA324DFD-0E44-4A24-AC13-9D580041D3DCQ35115128-5133D1B4-516F-49A0-85EC-C071F521D0FBQ35184303-958A0358-EE39-44B7-8A1A-986B60D42ED2Q35195104-BD9FF5AE-6DB3-4DA7-93C9-576BB617AF5EQ35216055-D3274748-6AA2-46E1-9E83-F5EF18E29CD7Q35510694-87159F44-54C6-4BFE-A167-EFED5F7E818BQ35540458-6F349289-6D8B-49FC-A631-F106D880C1F5Q35552529-1FC023B1-B5F7-4EC7-A52F-BECD79B517D5Q35628178-58B1A1AF-A102-4045-A6BC-1B514826A6DFQ35770723-104A7EFB-0609-4976-9086-50215DD8BEE0Q35907788-5F29AAFA-837A-45E9-AC33-C426E9613F17
P2860
The use of biochemical markers of bone turnover in osteoporosis. Committee of Scientific Advisors of the International Osteoporosis Foundation.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
The use of biochemical markers ...... ional Osteoporosis Foundation.
@ast
The use of biochemical markers ...... ional Osteoporosis Foundation.
@en
The use of biochemical markers ...... ional Osteoporosis Foundation.
@nl
type
label
The use of biochemical markers ...... ional Osteoporosis Foundation.
@ast
The use of biochemical markers ...... ional Osteoporosis Foundation.
@en
The use of biochemical markers ...... ional Osteoporosis Foundation.
@nl
prefLabel
The use of biochemical markers ...... ional Osteoporosis Foundation.
@ast
The use of biochemical markers ...... ional Osteoporosis Foundation.
@en
The use of biochemical markers ...... ional Osteoporosis Foundation.
@nl
P2093
P50
P356
P1476
The use of biochemical markers ...... tional Osteoporosis Foundation
@en
P2093
Committee of Scientific Advisors of the International Osteoporosis Foundation]
P D Delmas
P2888
P356
10.1007/S001980070002
P407
P478
11 Suppl 6
P577
2000-01-01T00:00:00Z
P6179
1025267804